• ATTC/CTN Webinar Series: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl. February 25, 2026, 11am-12:30pm PT. 1.5 CME/CE Available.
    Events,  Node News

    Western States Node Webinar: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (Feb 25, 2026) CME available!

    Join the CTN Western States Node and the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) for their next joint webinar, February 25, 2026, 11am-12:30pm PT! In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine for people using fentanyl, including precipitated or prolonged withdrawal, patient reports that buprenorphine was ineffective, and patient preference for methadone. In response to these challenges, most clinicians surveyed reported modifying their standard induction protocols or patient counseling approaches. Clinicians treating larger patient volumes, seeing a high proportion of patients using fentanyl, or initiating treatment in non-inpatient settings were more likely to report difficulties starting patients on buprenorphine. Dr. Winstanley will present the study results and discuss their implications. 1.5 CME/CE available! For information about credit types and accreditation, as well as learning objectives for this session, download the webinar flyer. Register for the webinar here! Posted on February 11, 2026

  • Details for the January 2025 T&I SIG webinar
    Events,  SIG Updates

    WATCH THE RECORDING: T&I SIG Meeting: Scoping Review of Implementation Strategies to Reduce Stigma in Healthcare Settings (Jan 20, 2026, 9am PT)

    The recording from the CTN Translation & Implementation (T&I) SIG meeting on January 20, 2026 (9-10am PT), featuring guest speakers Camille Cioffi, PhD (Oregon Research Institute, University of OR), and Bryan Hartzler, PhD (Addictions, Drug & Alcohol Institute, University of WA), is now available! Stigma toward people with substance use disorders (SUD) remains a major barrier to care. In their session, titled, “A Scoping Review of Implementation Strategies to Reduce Stigma Toward People Who Use Substances in Healthcare Settings,” Drs. Cioffi and Hartzler described the methods, results, and implications of a scoping review completed by the CTN T&I SIG Implementation Strategies Workgroup to identify and describe implementation strategies used to reduce stigmatizing attitudes toward people with SUD in healthcare settings. Watch the recording! Posted on December 12, 2025, updated January 21, 2026

  • CTN Primary Care SIG
    Events,  SIG Updates

    CTN Primary Care SIG: Whole-Person Care for People Who Use Methamphetamine (Jan. 26, 2026, 12-1pm ET)

    The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices. Next Primary Care SIG Meeting Whole Person Primary Care for Persons Who Use Methamphetamine: Hearts, Lungs, Bugs, and BrainsJanuary 26, 2026 | 12-1pm ET Steven Shoptaw, PhDGeorge F Kneller Term Chair in Family Medicine, UCLAVice Chair of Research and Professor in Family Medicine, UCLA Join Zoom MeetingMeeting ID: 943 3434 2090Passcode: 370819 Primary Care SIG Schedule and Leadership The Primary Care SIG is led by Claire Simon, MD and Sebastian Tong, MD, MPH, and meets every other month on the 4th Monday of the month from 9-10am PT/12-1pm ET. To join the Primary Care SIG webinar series listserv, please provide your contact information here. Posted on December 18, 2025

  • CPDD 2026
    Events

    CPDD 2026: Submit your abstracts to the Publications Committee ASAP!

    Submissions of abstracts for posters and oral presentations are now open for CPDD 2026, which will be held in Portland, Oregon from June 13-17, 2026. The CPDD Submission Deadline is December 4.   All abstracts must be approved by the CTN Publications Committee prior to submission to CPDD. Please submit CPDD abstracts to the PC as soon as possible for review to facilitate approval prior to the Thanksgiving holiday.    Submit your abstracts to Jack Blaine (jblaine@nih.gov) and Susan Sonne (sonnesc@musc.edu).

  • GIN On the Rocks, Oct 20, 2025, 1-2pm MST. Across the Continuum: Community-Engaged Research on Substance Use
    Events,  Node News

    Greater Intermountain Node (GIN) On the Rocks Webinar Series: Community-Engaged Research (Oct. 20, 2025, 1pm MST)

    Join the CTN Greater Intermountain Node on October 20, 2025 (1-2pm MST) for the next installment of their GIN On the Rocks webinar series: Across the Continuum: Community-Engaged Research on Substance Use Presenter: Jordan A. Dyett, PhD, LCSWAssistant ProfessorDivision of Social Work, University of Wyoming In this session, Jordan A. Dyett, PhD, LCSW, of the University of Wyoming, will outline the community-engaged research continuum and key methodological considerations for partnering with communities. She will share examples from her research to illustrate different points along the continuum and show how this approach complements other methods in addressing the drug crisis. In-person: Colorow Building, Seminar Room 204, University of Utah (383 Colorow Way, Salt Lake City, UT)On Zoom: Meeting ID: 810 3810 4237; passcode: ginotr Posted on October 13, 2025

  • CTN T&I SIG: Partnering with Tribal Clinics to Culturally Center the Delivery of Medication Treatment for Opioid Use Disorder: Primary Outcomes from a Formative Implementation Study. November 18, 2025 (9-10am PT)
    Events,  SIG Updates

    CTN T&I SIG: Partnering with Tribal Clinics to Culturally Center the Delivery of Medication Treatment for Opioid Use Disorder (Nov. 18, 9am PT)

    Join the CTN Translation & Implementation (T&I) SIG on November 18, 2025 (9-10am PT) for their next session: Partnering with Tribal Clinics to Culturally Center the Delivery of Medication Treatment for Opioid Use Disorder: Primary Outcomes from a Formative Implementation Study, presented by Aimee Campbell, PhD and Kamilla Venner, PhD. American Indian/Alaska Native (AI/AN) people exhibit many cultural strengths and resiliencies, yet rates of opioid overdose mortality continue to be the highest of all racial/ethnic groups in the U.S. This presentation will describe the development and testing of an implementation intervention, in partnership with four AI/AN-serving clinics, to culturally center the delivery of MOUD in order to improve implementation outcomes. See flyer for more details. Contact Elena Rosenberg-Carlson at rosenbee@stanford.edu for the meeting link or to join the CTN T&I SIG listserv.

  • CPDD 88th annual scientific meeting 2026
    Events

    CPDD 2026: Submissions Open!

    Submissions for symposia, workshops, posters, and more are now open for CPDD 2026, which will be held in Portland, Oregon from June 13-17, 2026. Deadlines: Don’t forget that all conference submissions have to be approved by the Publications Committee first! Find out more about CPDD 2026 here! Posted on September 29, 2025

  • CTN Youth SIG: Upcoming webinar
    Events,  SIG Updates

    CTN Youth SIG: Advancing Equity Through Implementation Science in Adolescent Substance Use Prevention (Nov. 21, 2025)

    The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: Advancing Equity Through Implementation Science in Adolescent Substance Use PreventionFriday, November 21, 2025 (11:00 a.m.–12:00 p.m. ET) Presenter:Cady Berkel, PhDAssociate ProfessorCollege of Health SolutionsArizona State University Culturally and contextually grounded preventive interventions can address upstream risk and protective factors to improve equity, but only if they are implemented in systems that serve underrepresented groups. This presentation will share findings a program of community-based research conducted in partnership with multiple settings (e.g., pediatric primary care, family courts, corrections) to advance equitable access to evidence-based substance use prevention for adolescents and families. The talk will also discuss implementation science frameworks and designs to incorporate equity and accelerate the translation of research into practice. About the presenter Dr. Cady Berkel is an Associate Professor in the College of Health Solutions at Arizona State University whose program of federally funded research focuses on advancing equitable access to evidence-based substance use prevention for adolescents and families. Her work to embed parenting interventions in primary care was recognized by NIDA’s Substance Use Prevention Services in Primary Care Challenge. She also serves in national leadership roles, including as a National Advisory Council member for SAMHSA’s Center for Substance Abuse Prevention, a Subject Matter Expert for the CDC’s Community Preventive Services Task Force review of substance use prevention, and Co-Chair of the Society for Prevention Research Standards of Evidence Task Force. Register for the webinar here!

  • Node News
    Events,  Node News,  Protocol News

    News from the Greater Intermountain Node: Upcoming Cannabis Seminar and CTN-0151 Updates

    Greater Intermountain Node Seminar Series “On the Rocks” On the Rocks (OTR) is the Greater Intermountain Node’s (GIN) monthly Research Discussion Series, spotlighting standout addiction-related research from across the Greater Intermountain community. Designed for dynamic exchange, OTR fosters collaboration and fresh thinking through interactive conversations between presenters and attendees. The series name nods to the stunning Rocky Mountain backdrop and the iconic Utah trails just steps from our offices. Join us for the next OTR on Wednesday, October 1, 2025, from 12–1 PM MST, featuring “Cannabis: Balancing Risk and Therapeutic Potential” with Marcel O. Bonn-Miller, PhD. Dr. Bonn-Miller will share insights from three key research areas: Cannabis Use Disorder, the therapeutic promise of cannabinoids, and regulatory science. He’ll present findings on cannabis use among veterans with PTSD, explore cannabinoid-based treatments for sleep, anxiety, and substance use disorders, and discuss CBD safety standards and regulatory frameworks. Dr. Bonn-Miller holds a BA and PhD in clinical psychology from the University of Vermont and completed a postdoctoral fellowship at Stanford. He launched his research career at the VA and University of Pennsylvania, later leading cannabis research in both academic and industry settings. He now serves as Chief Scientific Officer at Charlotte’s Web and has authored over 175 peer-reviewed publications. Visit the OTR website to learn how to join. Free CME/CE credit available for live attendees. CTN-0151 Update The Greater Intermountain Node is proud to collaborate with the University of Tennessee Health Science Center, Dr. Kenneth Hohmeier, and Dr. Rachel Barenie on CTN-0151:…